Ravi Salgia to Feasibility Studies
This is a "connection" page, showing publications Ravi Salgia has written about Feasibility Studies.
Connection Strength
0.018
-
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma. Cancer. 2008 Aug 15; 113(4):808-14.
Score: 0.018
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.